ENVALITH
ヒューマン・メタボローム・テクノロジーズ株式会社 logo

Human Metabolome Technologies, Inc.

6090・Standard Market・Services

Official website
ヒューマン・メタボローム・テクノロジーズ株式会社 logo
Human Metabolome Technologies, Inc.6090
Reference Indicators

Market Cap

35¥100M

P/E (Forecast)

16.5x

P/B

1.8x

Dividend Yield (Forecast)

3.07%

ROE

13.6%

EV/EBITDA

5.7x
Financial Summary
Unit: ¥M
Item
2022Jun 2022
2023Jun 2023
2024Jun 2024
2025Jun 2025
Net Sales
1,2231,2991,3451,455
Cost of Sales
383439476533
Gross Profit
840859869921
SG&A Expenses
648648649672
Operating Income
191210220249
Non-operating Income
6424234
Non-operating Expenses
22213
Ordinary Income
253232241240
Extraordinary Income
942135
Extraordinary Losses
0—07
Pre-tax Income
261237261269
Income Taxes
-5-481813
Net Income
267285243256
EBITDA
256291306353
Gross Margin
68.7%66.2%64.6%63.3%
Operating Margin
15.6%16.2%16.4%17.1%
ROA
12.9%12.5%9.3%10.8%
ROE
20.8%18.4%13.5%13.6%
Segment Performance
Unit: ¥M
2025
SegmentNet SalesOperating IncomeOperating Margin
先端研究開発支援事業1,14318416.1%
ヘルスケア・ソリューション事業3116420.6%